Atlas targeted genomic newborn screening platform
Integrated DNA extraction, capture based library preparation and bioinformatics for newborn screening laboratories.
Integrated DNA extraction, capture based library preparation and bioinformatics for newborn screening laboratories.
Modular genomic newborn screening for sustainable program expansion.
Comprehensive gene sequencing for cystic fibrosis, severe combined immunodeficiency, metabolic conditions, IEMs, lysosomal disorders.
Comprehensive gene sequencing to identify exonic and non-coding variants in multi ethnic populations.
Validated analytical sensitivity greater than whole genome sequencing.
Streamlined laboratory workflow from DNA extraction to report generation.
Low volume and high volume platforms.
Includes sample management, QC, bioinformatics and reporting.
Integrated primary, secondary and tertiary analysis of SNVs, in/dels, and CNVs including those in genes with high homology e.g. SMN1.
With Atlas, we’re enabling high-throughput targeted gene sequencing from a heel prick dried blood spot sample that can be incorporated into newborn screening programs. The Atlas platform delivers a unique combination of simple setup processes, automation and user friendly software to simplify testing.